{
    "startDate": "2020-01-01",
    "endDate": "2020-09-30",
    "year": "2020",
    "quarter": "Q3",
    "symbol": "BLGO",
    "data": {
        "bs": [
            {
                "label": "Common stock, $.00067 Par Value, 400,000,000 shares authorized, 166,256,024 and 221,682,140 shares issued, at December 31, 2019 and September 30, 2020, respectively.",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 148000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 1117000
            },
            {
                "label": "Right-of-use, operating lease, net of amortization",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 356000
            },
            {
                "label": "Long-term debt, noncurrent",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 507000
            },
            {
                "label": "Discount on convertible notes payable and line of credit, net of amortization",
                "concept": "blgo:DiscountOnConvertibleNotesPayableCurrent",
                "unit": "usd",
                "value": 149000
            },
            {
                "label": "Deferred offering cost",
                "concept": "blgo:DeferredOfferingCostsNoncurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Property and equipment, net of depreciation",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 42000
            },
            {
                "label": "Accounts Payable and Accrued Liabilities, Current, Total",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 766000
            },
            {
                "label": "Total BioLargo, Inc. and subsidiaries stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 4677000
            },
            {
                "label": "Lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 114000
            },
            {
                "label": "Deferred revenue and deposits",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 72000
            },
            {
                "label": "Commitments and contingencies (Note 11)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred Series A, $.00067 Par Value, 50,000,000 shares authorized, -0- shares issued and outstanding, at December 31, 2019 and September 30, 2020, respectively.",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -107000
            },
            {
                "label": "Accounts receivable, net of allowance",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 413000
            },
            {
                "label": "Other non-current assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 823000
            },
            {
                "label": "Investment in South Korean Joint Venture",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": 73000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 5188000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 135033000
            },
            {
                "label": "Total stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 480000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 3189000
            },
            {
                "label": "Note payable",
                "concept": "NotesPayableCurrent",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Line of credit",
                "concept": "LinesOfCreditCurrent",
                "unit": "usd",
                "value": 223000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 51000
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity (deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 5188000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -130397000
            },
            {
                "label": "Discount on convertible notes payable, net of amortization",
                "concept": "blgo:DiscountOnConvertibleNotesPayableNetOfCurrentPortion",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Non-controlling interest (Note 8)",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": -4197000
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 1873000
            },
            {
                "label": "Inventories, net of allowance",
                "concept": "InventoryNet",
                "unit": "usd",
                "value": 292000
            },
            {
                "label": "Lease liability",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 241000
            },
            {
                "label": "In-process research and development (Note 8)",
                "concept": "FiniteLivedIntangibleAssetsNet",
                "unit": "usd",
                "value": 2021000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 4708000
            }
        ],
        "cf": [
            {
                "label": "Fair value of warrants issued with convertible notes",
                "concept": "OtherSignificantNoncashTransactionValueOfConsiderationGiven1",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from convertible notes payable",
                "concept": "blgo:ProceedsFromSaleOfConvertibleNotesPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Repayment of note payable",
                "concept": "RepaymentsOfNotesPayable",
                "unit": "usd",
                "value": 25000
            },
            {
                "label": "Repayment of line of credit Clyra Medical",
                "concept": "RepaymentsOfLongTermLinesOfCredit",
                "unit": "usd",
                "value": 27000
            },
            {
                "label": "Leasehold improvements",
                "concept": "PaymentsToAcquireMachineryAndEquipment",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 37000
            },
            {
                "label": "Fair value of Clyra shares issued as a commitment fee",
                "concept": "blgo:StockReceivedForCommitmentFee",
                "unit": "usd",
                "value": 70000
            },
            {
                "label": "Proceeds from sales of common stock",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 2380000
            },
            {
                "label": "Common stock issued for interest",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 184000
            },
            {
                "label": "Net change in cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 462000
            },
            {
                "label": "Deemed dividend",
                "concept": "blgo:DeemedDividends",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Sale of equipment",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 4000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 69000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -7707000
            },
            {
                "label": "Common stock issued in lieu of salary to officers and fees for services from vendors",
                "concept": "IssuanceOfStockAndWarrantsForServicesOrClaims",
                "unit": "usd",
                "value": 542000
            },
            {
                "label": "Depreciation expense",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 50000
            },
            {
                "label": "Proceeds from warrant exercise",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Interest expense related to the fair value of warrants issued as consent for variable debt",
                "concept": "blgo:InterestExpenseFairValueOfWarrantsIssuedAsConsentForVariableDebt",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -3318000
            },
            {
                "label": "Investment in South Korean joint venture",
                "concept": "PaymentsToAcquireInterestInJointVenture",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Income taxes",
                "concept": "IncomeTaxesPaid",
                "unit": "usd",
                "value": 2000
            },
            {
                "label": "Bad debt expense",
                "concept": "ProvisionForDoubtfulAccounts",
                "unit": "usd",
                "value": 11000
            },
            {
                "label": "Customer deposits",
                "concept": "blgo:IncreaseDecreaseInDepositsWithCustomer",
                "unit": "usd",
                "value": -1000
            },
            {
                "label": "Loss on extinguishment of debt",
                "concept": "blgo:ExtensionExpenseDebt",
                "unit": "usd",
                "value": 442000
            },
            {
                "label": "Net effect of foreign currency translation",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
                "unit": "usd",
                "value": -8000
            },
            {
                "label": "Loss on investment in ODIN",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -27000
            },
            {
                "label": "Proceeds from SBA program loans",
                "concept": "ProceedsFromIssuanceOfUnsecuredDebt",
                "unit": "usd",
                "value": 507000
            },
            {
                "label": "Deferred offering expense",
                "concept": "blgo:DeferredOfferingCostExpense",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Proceeds from line of credit Clyra Medical",
                "concept": "ProceedsFromLongTermLinesOfCredit",
                "unit": "usd",
                "value": 200000
            },
            {
                "label": "Allocation of stock option expense within noncontrolling interest",
                "concept": "blgo:AllocationOfStockOptionExpenseWithinNoncontrollingInterest",
                "unit": "usd",
                "value": 448000
            },
            {
                "label": "Interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 81000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 12000
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 164000
            },
            {
                "label": "Inventories",
                "concept": "IncreaseDecreaseInInventories",
                "unit": "usd",
                "value": 273000
            },
            {
                "label": "Interest expense related to amortization of the discount on convertible notes payable and line of credit",
                "concept": "AmortizationOfFinancingCostsAndDiscounts",
                "unit": "usd",
                "value": 1575000
            },
            {
                "label": "Increase in liability to Clyra Medical shareholder",
                "concept": "LiabilitiesAssumed1",
                "unit": "usd",
                "value": 129000
            },
            {
                "label": "Allocation of Clyra stock to noncontrolling interest",
                "concept": "blgo:AllocationOfStockToNoncontrollingInterest",
                "unit": "usd",
                "value": 4075000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 3884000
            },
            {
                "label": "Stock option compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1712000
            },
            {
                "label": "Lincoln Park deferred offering costs, recorded as additional paid-in capital",
                "concept": "blgo:CommitmentFeeRecordedAsAdditionalPaidInCapital",
                "unit": "usd",
                "value": -122000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -96000
            }
        ],
        "ic": [
            {
                "label": "Loss on debt extinguishment",
                "concept": "GainsLossesOnExtinguishmentOfDebt",
                "unit": "usd",
                "value": -442000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 1031000
            },
            {
                "label": "Foreign currency translation",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -8000
            },
            {
                "label": "Operating loss",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -5615000
            },
            {
                "label": "Net loss attributable to common stockholders",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -6806000
            },
            {
                "label": "Net loss",
                "concept": "blgo:ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability",
                "unit": "usd",
                "value": -7707000
            },
            {
                "label": "Selling, general and administrative expenses",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 5345000
            },
            {
                "label": "Comprehensive loss attributable to common stockholders",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -6814000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -7715000
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -901000
            },
            {
                "label": "Gross profit",
                "concept": "GrossProfit",
                "unit": "usd",
                "value": 761000
            },
            {
                "label": "Tax credit",
                "concept": "blgo:TaxCreditIncome",
                "unit": "usd",
                "value": 109000
            },
            {
                "label": "Grant income",
                "concept": "blgo:NonoperatingIncomeGrantIncome",
                "unit": "usd",
                "value": 64000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 1823000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -7707000
            },
            {
                "label": "Net loss attributable to noncontrolling interest",
                "concept": "blgo:DeemedDividendForTheChangeInAccountingForDerivativeLiability",
                "unit": "usd",
                "value": -901000
            },
            {
                "label": "Loss per share attributable to common stockholders \u2013 basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.04
            },
            {
                "label": "Revenue",
                "concept": "RevenueFromContractWithCustomerIncludingAssessedTax",
                "unit": "usd",
                "value": 1522000
            },
            {
                "label": "Weighted average number of common shares outstanding: (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 182959765
            },
            {
                "label": "Total other expense:",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": -2092000
            }
        ]
    }
}